OTLC stock

Oncotelic Therapeutics Inc (OTLC) financials · P/E 0.1, rev $250.0K

Oncotelic Therapeutics Inc (OTLC) P/E 0.1, rev $250.0K.

Cached annual income statement
LineFY2025FY2024
Revenue$0$0
Cost of Revenue$0$0
Gross Profit$0$0
Operating Income-$3.2M-$3.6M
Net Income$249.3M-$4.5M
EPS (Diluted)$0.59$-0.01
Cached annual balance sheet
LineFY2025FY2024
Total Assets$393.1M$26.7M
Current Assets$1.2M$134.2K
Cash & Equivalents$88.9K$86.1K
Inventory$0$0
PP&E$0$0
Total Liabilities$131.4M$19.2M
Current Liabilities$18.1M$19.2M
Short-term Debt$0$2.4M
Long-term Debt$0$0
Total Debt$0$0
Shareholders' Equity$262.8M$8.3M
Retained Earnings$211.2M-$38.0M
Cached annual cash flow
LineFY2025FY2024
Operating Cash Flow-$1.4M-$740.3K
CapEx$0$0
Investing Cash Flow$0$0
Financing Cash Flow$1.4M$656.0K
Dividends Paid$0$0
Net Change in Cash$2.7K$0
Free Cash Flow$0$0

FAQ

What is OTLC P/E and revenue?

Oncotelic Therapeutics Inc (OTLC) P/E 0.1, rev $250.0K.

What is OTLC revenue?

Oncotelic Therapeutics Inc last cached revenue is $0 (FY2025).

Is OTLC profitable?

Oncotelic Therapeutics Inc last cached net income is $249.3M.

What are OTLC total assets?

Oncotelic Therapeutics Inc last cached total assets are $393.1M.

What is OTLC free cash flow?

Oncotelic Therapeutics Inc last cached free cash flow is $0.

Not investment advice. Cached statements, not a live tape.